SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-023514
Filing Date
2017-10-04
Accepted
2017-10-04 16:09:06
Documents
1
Period of Report
2017-10-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4728
  Complete submission text file 0000899243-17-023514.txt   6076
Mailing Address 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
TEPPER ROBERT I (Reporting) CIK: 0001192595 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 171121673

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations